The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DRAIZE, J. H., WOODARD, G., & CALVERY, H. O. (1944) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)08751-8 · Cited by 2,602
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Development and bioavailability assessment of ramipril nanoemulsion formulation
Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F. J., Khar, R. K., & Ali, M. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.014 · Cited by 817
Kommuru, T. R., Gurley, B., Khan, M. A., & Reddy, I. K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00614-1 · Cited by 624
(2000) · Veterinary Ophthalmology · doi:10.1046/j.1463-5224.2000.00300100.x · Cited by 614
Grant, W. M. (1962) · Thomas eBooks · Cited by 579
Analytical profiles of drug substances and excipients
(1997) · Analytica Chimica Acta · doi:10.1016/s0003-2670(97)89601-8 · Cited by 521
Microemulsions: An Overview and Pharmaceutical Applications
Tenjarla, S. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i5.20 · Cited by 428
Bioadhesive drug delivery systems
Nielsen, L. S., Schubert, L., & Hansen, J. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10004-5 · Cited by 403
Felt, O. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00003-4 · Cited by 358
Microemulsions as ocular drug delivery systems: recent developments and future challenges
Vandamme, T. F. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00017-9 · Cited by 345
Transdermal delivery of ketoprofen using microemulsions
Rhee, Y.-S., Choi, J.-G., Park, E.-S., & Chi, S.-C. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00827-4 · Cited by 321
A study of microemulsion systems for transdermal delivery of triptolide
Chen, H., Chang, X., Weng, T., Zhao, X., Gao, Z., Yang, Y., Xu, H., & Yang, X. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.001 · Cited by 310
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
Kaur, I. P., & Smitha, R. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120002997 · Cited by 305
Ophthalmic drug delivery systems
Shell, J. W. (1984) · Survey of Ophthalmology · doi:10.1016/0039-6257(84)90168-1 · Cited by 291
Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour
Warisnoicharoen, W., Lansley, A. B., & Lawrence, M. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00406-8 · Cited by 268
Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors
Sugrue, M. F. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00006-3 · Cited by 258
Bioadhesive drug delivery systems
Duchêne, D. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90106-n · Cited by 199
Miyazaki, S., Suzuki, S., Kawasaki, N., Endo, K., Takahashi, A., & Attwood, D. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00825-0 · Cited by 198
New vehicle based on a microemulsion for topical ocular administration of dexamethasone
Fialho, S. L., & Da Silva‐Cunha, A. (2004) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2004.00914.x · Cited by 193
Acetazolamide: future perspective in topical glaucoma therapeutics
Kaur, I. P., Smitha, R., Aggarwal, D., & Kapil, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00438-6 · Cited by 192
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Hayashi, T., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00050-0 · Cited by 188
Pharmacological Therapy for Glaucoma: A Review
Hoyng, P. F. J., & van Beek, L. M. (2000) · Drugs · doi:10.2165/00003495-200059030-00003 · Cited by 185
Effect of compaction pressure on the dissolution efficiency of some direct compression systems.
Khan, K. A., & Rhodes, C. T. (1972) · PubMed · Cited by 183
The potential of lipid emulsion for ocular delivery of lipophilic drugs
Shunmugaperumal, T., & Benita, S. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.033 · Cited by 167
Biopharmaceutics of Ocular Drug Delivery
Edman, P. (2019) · CRC Press eBooks · doi:10.1201/9780429284755 · Cited by 160
Lee, P. J., Langer, R., & Shastri, V. P. (2003) · Pharmaceutical Research · doi:10.1023/a:1022283423116 · Cited by 158
Adverse effects of topical antiglaucoma drugs on the ocular surface
Arıcı, M. K., Arıcı, D. S., Topalkara, A., & Güler, C. (2000) · Clinical and Experimental Ophthalmology · doi:10.1046/j.1442-9071.2000.00237.x · Cited by 156
Colloidal Carriers for Ophthalmic Drug Delivery
Mainardes, R. M., Urban, M. C. C., Cinto, P. O., Khalil, N. M., Chaud, M. V., Evangelista, R. C., & Gremião, M. P. D. (2005) · Current Drug Targets · doi:10.2174/1389450053765914 · Cited by 155
Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels
Zignani, M., Tabatabay, C., & Gurny, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00015-y · Cited by 127
The Development of Topical Carbonic Anhydrase Inhibitors
Maren, T. H. (1995) · Journal of Glaucoma · doi:10.1097/00061198-199502000-00012 · Cited by 117
Aboofazeli, R., & Lawrence, M. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90174-e · Cited by 116
Alany, R. G., Tucker, I. G., Davies, N. M., & Rades, T. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100000125 · Cited by 114
Garti, N., Aserin, A., Tiunova, I. M., & Fanun, M. (2000) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00486-6 · Cited by 110
Moreno, M. A., Ballesteros, M. P., & Frutos, P. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10412 · Cited by 105
Terry, J. E. (1978) · Archives of Ophthalmology · doi:10.1001/archopht.1978.03910050076019 · Cited by 101
Yamaguchi, M., Yasueda, S.-I., Isowaki, A., Yamamoto, M., Kimura, M., Inada, K., & Ohtori, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.036 · Cited by 100
Causes of blindness in the adult population of the Republic of Ireland
Munier, A., Gunning, T., Kenny, D., & O’Keefe, M. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.6.630 · Cited by 100
Roggeband, R., York, M., Pericoi, M., & Braun, W. H. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00057-0 · Cited by 79
Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea
Muchtar, S., Abdulrazik, M., Frucht‐Pery, J., & Benita, S. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01503-9 · Cited by 62
Trotta, M., Gallarate, M., Pattarino, F., & Carlotti, M. E. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00281-1 · Cited by 59
Evaluation of ocular irritation in the rabbit: Objective versus subjective assessment
Conquet, P., Durand, G., Laillier, J., & Plazonnet, B. (1977) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(77)90185-5 · Cited by 59
Liu, Z., Nie, S., Guo, H., et al. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.1.0006 · Cited by 58
Effects of Three Penetration Enhancers on Transcorneal Permeation of Cyclosporine
van der Bijl, P., Eyk, A. D. V., & Meyer, D. (2001) · Cornea · doi:10.1097/00003226-200107000-00013 · Cited by 54
Blindness in glaucoma patients
Blomdahl, S., Calissendorff, B., Tengroth, B., & Wallin, Ö. (1997) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1997.tb00155.x · Cited by 46
Radomska-Soukharev, A., & Wojciechowska, J. (2006) · PubMed · Cited by 41
Cited by
Nanoemulsions: Formation, properties and applications
Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016) · Soft Matter · doi:10.1039/c5sm02958a · Cited by 1,633
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
“Nanoemulsions can be rendered into several dosage forms, like liquids[5], creams[6, 7], sprays[8], gels[9, 10], aerosol[11, 12], foams[13]; and can be administered by equally varying routes like topical[14], oral[15], intravenous[16], intranasal[17], pulmonary[17] and ocular[18].”
BackgroundNanoparticles and nanofibers for topical drug delivery
Goyal, R., Macri, L. K., Kaplan, H. M., & Kohn, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.049 · Cited by 590
Recent advances in ocular drug delivery
Achouri, D., Alhanout, K., Piccerelle, P., & Andrieu, V. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.736515 · Cited by 335
Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs
Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., Saharan, R., Kumar, S., Geeta, & Sehrawat, R. (2023) · Scientifica · doi:10.1155/2023/6640103 · Cited by 331
Metadata
- Authors
- Ammar, H. O., Salama, H. A., Ghorab, M., & Mahmoud, A. A.
- Venue
- AAPS PharmSciTech
- Published
- 2009-06-18
- Volume
- 10
- Issue
- 3
- Pages
- 808-19
- ISSN
- 1530-9932 (ISSN-L)
- OpenAlex
- W2074417814
- Cited by
- 319
- References
- 48
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.